For people with type 2 diabetes who also have a history of diabetic retinopathy (a condition that can cause blood vessel damage in the retina), Zepbound may worsen symptoms
Injectable semaglutide, also known as a GLP-1 agonist , is an effective weight-loss solution that: Slows gastric emptying to promote fullness Reduces glucagon to prevent glucose spikes Increases insulin secretion to lower blood sugar* *Balancing blood sugar levels can also boost your mood, increase daily energy, reduce inflammation and help prevent long-term issues like heart disease, high blood pressure, high cholesterol and kidney disease
Switching from injectable semaglutide Unlike the tirzepatide-to-semaglutide switch discussed above, moving from injectable to oral semaglutide does not require restarting at the lowest dose
Trial watch: STING agonists in cancer therapy
I.C.4.a.4 Diabetic Complications and the With Convention: Per ICD-10-CM Guideline I.A.15, the word with in the Alphabetic Index or Tabular List establishes a presumed causal relationship between diabetes and listed conditions